Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study

References

• Aboud, M., Elgalib, A., Pomeroy, L., Panayiotakopoulos, G., Skopelitis, E., Kulasegaram, R., … Peters, B.S. (2010). Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: Implications for clinical management: The CREATE 1 study. International Journal of Clinical Practice, 64(9), 1252–1259.
   Google Scholar
• Anderson , K.M. , Wilson , P.W. , Odell , P.M. and Kannel , W.B. 1991 . An updated coronary risk profile. A statement for health professionals . Circulation , 83 ( 1 ) : 356 – 362 .
   PubMed Web of Science ®Google Scholar
• Bacchetti, P., Cofrancesco, J., Heymsfield, S., Lewis, C.E., Scherzer, R., Shlipak, M., & Tien, P.C. (2006). Fat distribution in women with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 42(5), 562–571.
   Google Scholar
• Bacchetti, P., Gripshover, B., Grunfeld, C., Heymsfield, S., McCreath, H., Osmond, D., … Tien, P. (2005). Fat distribution in men with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 40(2), 121–131.
   Google Scholar
• Currier, J., Scherzer, R., Bacchetti, P., Heymsfield, S., Lee, D., Sidney, S., & Tien, P.C. (2008). Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 48(1), 35–43.
   Google Scholar
• Currier, J.S., Taylor, A., Boyd, F., Dezii, C.M., Kawabata, H., Burtcel, B., … Hodder, S. (2003). Coronary heart disease in HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes, 33(4), 506–512.
   Google Scholar
• De Socio, G.V., Parruti, G., Quirino, T., Ricci, E., Schillaci, G., Adriani, B., … Bonfanti, P. (2008). Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: Results from the SIMONE study. Journal of Infections, 57(1), 33–40.
   Google Scholar
• Dolan, S.E., Hadigan, C., Killilea, K.M., Sullivan, M.P., Hemphill, L., Lees, R.S., … Grinspoon, S. (2005). Increased cardiovascular disease risk indices in HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 39(1), 44–54.
   Google Scholar
• El-Sadr, W.M., Mullin, C.M., Carr, A., Gibert, C., Rappoport, C., Visnegarwala, F., … Raghavan, S.S. (2005). Effects of HIV disease on lipid, glucose and insulin levels: Results from a large antiretroviral-naive cohort. HIV Medicine, 6(2), 114–121.
   Google Scholar
• Friedman, G.D., Cutter, G.R., Donahue, R.P., Hughes, G.H., Hulley, S.B., Jacobs, D.R., Jr., … Savage, P.J. (1988). CARDIA: Study design, recruitment, and some characteristics of the examined subjects. Journal of Clinical Epidemiology, 41(11), 1105–1116.
   Google Scholar
• Friis-Møller, N., Sabin, C.A., Weber, R., d'Arminio Monforte, A., El-Sadr, W.M., Reiss, P., … Lundgren, J.D. (2003). Combination antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine, 349(21), 1993–2003.
   Google Scholar
• Friis-Møller, N., Thiebaut, R., Reiss, P., Weber, R., Monforte, A.D., De Wit, S., … Law, M.G. (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: The data collection on adverse effects of anti-HIV drugs study. European Journal of Cardiovascular Prevention and Rehabilitation, 17(5), 491–501.
   Google Scholar
• Gallagher, D., Belmonte, D., Deurenberg, P., Wang, Z., Krasnow, N., Pi-Sunyer, F.X., & Heymsfield, S.B. (1998). Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. American Journal of Physiology, 275(2, Pt. 1), E249–E258.
   Google Scholar
• Galli, M., Veglia, F., Angarano, G., Santambrogio, S., Meneghini, E., Gritti, F., … Lazzarin, A. (2003). Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. Journal of Acquired Immune Deficiency Syndromes, 34(1), 58–61.
   Google Scholar
• Grunfeld, C., Delaney, J.A., Wanke, C., Currier, J.S., Scherzer, R., Biggs, M.L., … Kronmal, R.A. (2009). Preclinical atherosclerosis due to HIV infection: Carotid intima-medial thickness measurements from the FRAM study. AIDS, 23(14), 1841–1849.
   Google Scholar
• Grunfeld , C. , Kotler , D.P. , Hamadeh , R. , Tierney , A. , Wang , J. and Pierson , R.N. 1989 . Hypertriglyceridemia in the acquired immunodeficiency syndrome . American Journal of Medicine , 86 ( 1 ) : 27 – 31 .
   PubMed Web of Science ®Google Scholar
• Grunfeld , C. , Pang , M. , Doerrler , W. , Shigenaga , J.K. , Jensen , P. and Feingold , K.R. 1992 . Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome . Journal of Clinical Endocrinology & Metabolism , 74 ( 5 ) : 1045 – 1052 .
   PubMed Web of Science ®Google Scholar
• Grunfeld, C., Rimland, D., Gibert, C.L., Powderly, W.G., Sidney, S., Shlipak, M.G., … Heymsfield, S.B. (2007). Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. Journal of Acquired Immune Deficiency Syndromes, 46(3), 283–290.
   Google Scholar
• Hadigan, C., Meigs, J.B., Wilson, P.W., D'Agostino, R.B., Davis, B., Basgoz, N., … Grinspoon, S. (2003). Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clinical Infectious Diseases, 36(7), 909–916.
   Google Scholar
• Kaplan, R.C., Kingsley, L.A., Sharrett, A.R., Li, X., Lazar, J., Tien, P.C., … Gange, S.J. (2007). Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clinical Infectious Diseases, 45(8), 1074–1081.
   Google Scholar
• Kosmiski, L.A., Bacchetti, P., Kotler, D.P., Heymsfield, S.B., Lewis, C.E., Shlipak, M.G., … Grunfeld, C. (2008). Relationship of fat distribution with adipokines in human immunodeficiency virus infection. Journal of Clinical Endocrinology & Metabolism, 93(1), 216–224.
   Google Scholar
• Kotler , D.P. 2008 . HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients . Journal of Acquired Immune Deficiency Syndromes , 49 ( Suppl. 2 ) : S79 – S85 .
   PubMed Web of Science ®Google Scholar
• Lee, G.A., Seneviratne, T., Noor, M.A., Lo, J.C., Schwarz, J.M., Aweeka, F.T., … Grunfeld, C. (2004). The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS, 18(4), 641–649.
   Google Scholar
• Mulligan, K., Parker, R.A., Komarow, L., Grinspoon, S.K., Tebas, P., Robbins, G.K., … Dube, M.P. (2006). Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. Journal of Acquired Immune Deficiency Syndromes, 41(5), 590–597.
   Google Scholar
• Nieves, D.J., Cnop, M., Retzlaff, B., Walden, C.E., Brunzell, J.D., Knopp, R.H., … Kahn, S.E. (2003). The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes, 52(1), 172–179.
   Google Scholar
• Rossi, R., Nuzzo, A., Guaraldi, G., Orlando, G., Squillace, N., Ligabue, G., … Modena, M.G. (2009). The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 52(2), 303–304.
   Google Scholar
• Saint-Marc, T., Partisani, M., Poizot-Martin, I., Rouviere, O., Bruno, F., Avellaneda, R., … Touraine, J.L. (2000). Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study. AIDS, 14(1), 37–49.
   Google Scholar
• Snijder, M.B., Visser, M., Dekker, J.M., Goodpaster, B.H., Harris, T.B., Kritchevsky, S.B., … Seidell, J.C. (2005). Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia, 48(2), 301–308.
   Google Scholar
• Stein, J.H., Klein, M.A., Bellehumeur, J.L., McBride, P.E., Wiebe, D.A., Otvos, J.D., & Sosman, J.M. (2001). Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation, 104(3), 257–262.
   Google Scholar
• Tien , P.C. , Benson , C. , Zolopa , A.R. , Sidney , S. , Osmond , D. and Grunfeld , C. 2006 . The study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design, and sample characteristics . American Journal of Epidemiology , 163 ( 9 ) : 860 – 869 .
   PubMed Web of Science ®Google Scholar
• Tien, P.C., Cole, S.R., Williams, C.M., Li, R., Justman, J.E., Cohen, M.H., … Grunfeld, C. (2003). Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. Journal of Acquired Immune Deficiency Syndromes, 34(5), 461–466.
   Google Scholar
• Triant , V.A. , Lee , H. , Hadigan , C. and Grinspoon , S.K. 2007 . Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease . Journal of Clinical Endocrinology & Metabolism , 92 ( 7 ) : 2506 – 2512 .
   PubMed Web of Science ®Google Scholar
• Wohl, D., Scherzer, R., Heymsfield, S., Simberkoff, M., Sidney, S., Bacchetti, P., & Grunfeld, C. (2008). The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men. Journal of Acquired Immune Deficiency Syndromes, 48(1), 44–52.
   Google Scholar
• Yim , J.E. , Heshka , S. , Albu , J.B. , Heymsfield , S. and Gallagher , D. 2008 . Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk . Journal of Applied Physiology , 104 ( 3 ) : 700 – 707 .
   PubMed Web of Science ®Google Scholar